Document is current
Any future updates will be listed below
-
Authors
Kaeuferle, Theresa
Zwermann, Maximilian
Stoll, Nadine
Ferrada-Ernst, Paulina
Jablonowski, Lena
Zeidler, Reinhard
Willier, Semjon
Stenger, Dana
Yassin, Abdallah
Stripecke, Renata
Feuchtinger, Tobias
- License Information
-
More Information
Article History
Received: 19 December 2024
Accepted: 4 March 2025
First Online: 19 March 2025
Declarations
:
: This study involves human healthy donors and the study received approval from the local ethics committee: Ethikkommission bei der LMU München, Projekt Nr. 36–16. Consent was obtained directly from healthy donors.
: Not applicable.
: RS has filed a patent application for generation of CAR-T cells targeting lytic herpes infections and is a founding shareholder and scientific consultant of BioSyngen/Zelltechs Pte Ltd. The information provided in this publication is shared only for non-commercial purposes, and should not be used, directly or indirectly, for any commercial purposes.
